GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.260
+0.080 (3.67%)
May 4, 2026, 4:00 PM EDT - Market closed
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.27 million as of May 5, 2026. Its market cap has increased by 197.36% in one year.
Market Cap
3.27M
Enterprise Value
-4.89M
1-Year Change
197.36%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $3.27M, a decrease of -87.09%. That is a compound annual growth rate of -49.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 3.27M | 30.74% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galmed Pharmaceuticals | 3.76M |
| Ensysce Biosciences | 3.61M |
| Soligenix | 3.56M |
| GeoVax Labs | 3.34M |
| Artelo Biosciences | 3.18M |
| Decoy Therapeutics | 3.14M |
| HCW Biologics | 3.04M |
| Oragenics | 2.69M |